Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Cardinali

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|May 8, 2023
NPM1-mutated AML with starry sky patternBrunangelo Falini, Valeria Cardinali, Lorenzo Brunetti, et al.
Annals of Hematology|June 19, 2025
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndromeValeria Cardinali, Stefano Coiro, Maria Paola Martelli, et al.
Minerva Medica|September 21, 2020
Enasidenib and ivosidenib in AMLMaria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Hematological Oncology|July 11, 2024
Prescription patterns of venetoclax in acute myeloid leukemiaAndrealuna Ucciero, Giuseppe Traversa, Alessia Pisterna, et al.
The New England Journal of Medicine|September 6, 2018
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AMLEnrico Tiacci, Alessandra Venanzi, Stefano Ascani, et al.
Frontiers in Oncology|September 27, 2021
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic LeukemiaValerio Guarente, Giovanni Martino, Erica Dorillo, et al.
Haematologica|January 9, 2025
Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life studyMatteo Dragani, Michela Ansuinelli, Cristina Papayannidis, et al.
Leukemia|August 25, 2022
Current status and future perspectives in targeted therapy of NPM1-mutated AMLRoberta Ranieri, Giulia Pianigiani, Sofia Sciabolacci, et al.
Annals of Hematology|December 27, 2023
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvementGiovanni Martino, Gaetano Cimino, Matteo Caridi, et al.
Annals of Hematology|July 22, 2023
One disease, two faces: clonally-related AML and MPDCP with skin involvementGiovanni Martino, Gaetano Cimino, Matteo Caridi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|May 8, 2023
NPM1-mutated AML with starry sky patternBrunangelo Falini, Valeria Cardinali, Lorenzo Brunetti, et al.
Annals of Hematology|June 19, 2025
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndromeValeria Cardinali, Stefano Coiro, Maria Paola Martelli, et al.
Minerva Medica|September 21, 2020
Enasidenib and ivosidenib in AMLMaria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Hematological Oncology|July 11, 2024
Prescription patterns of venetoclax in acute myeloid leukemiaAndrealuna Ucciero, Giuseppe Traversa, Alessia Pisterna, et al.
The New England Journal of Medicine|September 6, 2018
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AMLEnrico Tiacci, Alessandra Venanzi, Stefano Ascani, et al.
Frontiers in Oncology|September 27, 2021
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic LeukemiaValerio Guarente, Giovanni Martino, Erica Dorillo, et al.
Haematologica|January 9, 2025
Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life studyMatteo Dragani, Michela Ansuinelli, Cristina Papayannidis, et al.
Leukemia|August 25, 2022
Current status and future perspectives in targeted therapy of NPM1-mutated AMLRoberta Ranieri, Giulia Pianigiani, Sofia Sciabolacci, et al.
Annals of Hematology|December 27, 2023
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvementGiovanni Martino, Gaetano Cimino, Matteo Caridi, et al.
Annals of Hematology|July 22, 2023
One disease, two faces: clonally-related AML and MPDCP with skin involvementGiovanni Martino, Gaetano Cimino, Matteo Caridi, et al.
Pageof 3